Ginkgo Bioworks
Venture Capital
NYSE-listed synthetic biology platform company (DNA) that creates and funds spinout companies in biotech, agriculture, and industrial biology.
Boston, United States · 4+ investments
Seed
Early Stage
Agtech
Biotech
Synthetic Biology
- Headquarters
- Boston, United States
- Founded
- 2009
- Website
- ginkgo.bio
- Total Investments
- 4
- Last Investment
- Nov 2021
- Geographic Focus
- United States
Investment Thesis
Funds spinout companies via the Ferment Consortium ($350M vehicle) to commercialize synthetic biology applications in established industries.
Ginkgo Bioworks is a Venture Capital firm based in Boston, United States. It has made 4 investments in Agtech and Biotech.
Investment History
Sign up to view investment history
Create a free account to see deal history, investment amounts, and round details.